As glucose intolerance and insulin resistance have been linked to ALS [24], [25], and in light of the neurotrophic and protective actions of GLP-1R activation in diverse cellular and animal models of neurodegeneration, we hypothesize that GLP-1 and analogues may provide neuroprotective actions in ALS. The gene discussed is GCG; the disease is amyotrophic lateral sclerosis.